International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-1 doi: 10.5281/zenodo.13373891
Original Research Article
ROLE OF LIPID PROFILE IN ACUTE ISCHEMIC STROKE
Published
Jan. 25, 2025
Abstract

Introduction: Stroke is defined as rapidly developing symptoms and/or signs of focal and global loss of cerebral function lasting for at least 24 hours with no apparent cause other than of vascular origin. It constitutes a dreadful burden of disability. Modifiable risk factors include hypertension, diabetes and hypercholesterolemia, atrial fibrillation, smoking, drug abuse, and alcohol intake. Changes in the lipid profile have been suggested with formation of atherosclerosis. Aims and objective: To evaluate lipid profile levels in patient with acute ischemic stroke and to compare this parameter with severity of stroke. Materials and methods: The cross-sectional study of one and half year duration (Feb2021-Aug2022) was done on 100 patients of acute ischemic stroke presented to K.R. Hospital, Mysore. The main goal was to determine whether hypercholesterolemia is a risk factor for high severity.Lipid profile was measured by collecting the patients’ blood after fasting for 9 to 12 hours. Severity of stroke was assessed by NIHSS. Based on NIHSS scores divided into minor (1-4), moderate (5-15), moderate to severe (16- 20), severe (21-42) groups. Along with assessment with severity, lipid profile was compared between severity of stroke. Statistical analysis: Data analysed using SPSS software version 22.0 and it will be presented as descriptive statistics in form of frequency table and graphs. Association between variables will be done using chi-square test and unpaired t test for qualitative and quantitative variables. Result will be expressed as mean+/-SD. Correlation of parameters is done by Pearson’s correlation formula. A p value of <0.05 is considered statistically significant. Results and conclusion: Among 100 cases higher levels of TC, TGL, LDL were associated with more severity of stroke. 9 were in minor group, 47 were in moderate group, 29 were in moderate to severe group, 15 were in severe group. As the severity increases the mean level of TC, TGL, LDL, VLDL also increases, mean HDL level decreases. P value being <0.05, statistically Significant, showing clinical correlation with severity of stroke. Higher TC, TGL, LDL and lower HDL increases the risk of severity of stroke. Association Were strong for higher level of TC and LDL Early detection and treating with lipid lowering drugs helps to reduce the risk and prevent morbidity and mortality.

Recommended Articles
Loading Image...
Volume-6, Issue-1
Citations
338 Views
160 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved